UGT is a microsomal glycosyltransferase. The enzyme catalyzes the glucuronosylation reaction of glucuronic acid with a large number of chemicals. With the cloning of the UGT gene and the successful expression of the gene product, the function and gene structure of UGT have become better understood. UGT is mainly found in the endoplasmic reticulum membrane and nuclear membrane of hepatocytes. It is also present to varying degrees in other organs and tissues such as the kidney, gastrointestinal tract, skin, brain, etc. UGT metabolizes not only foreign chemicals but also endogenous chemicals such as bilirubin, short-chain fatty acids, bile acids, and fat-soluble vitamins. In addition, UGT has an important physiological role in the metabolism of steroids and thyroid hormones. It is also involved in the biosynthesis of sugar esters in the brain and the clearance of aromatic substances.
At CD BioGlyco, our UGT addresses these limitations by leveraging advanced gene engineering techniques to develop customized, highly efficient, and robust enzymes. Our service is designed to unlock the full potential of these biocatalysts, providing a powerful tool for researchers and developers in the pharmaceutical, chemical, and agricultural sectors.
We employ advanced gene editing to make highly specific changes to the UGT gene. This technology allows us to precisely target and alter specific nucleotides, introducing point mutations, insertions, or deletions to modify the enzyme's amino acid sequence. This targeted approach is ideal for rational design strategies where specific residues are known to be critical for substrate binding or catalytic function.
CD BioGlyco has realized knockdown, insertion, suppression, overexpression, and many other purposes of genes. Our team will provide the best quality UGT gene editing services. The services include but are not limited to the following.
Fig.1 Types of UGT gene editing. (CD BioGlyco)
UGT1A1
UGT1A1 is a member of the phase II metabolizing enzyme family and the only enzyme that metabolizes detoxified bilirubin. UGT1A1 all possibilities of genetically related disorders include GS and CN, neurological disorders, hepatic and biliary disorders, metabolic difficulties, gallstones, cardiovascular disease, diabetes mellitus, leukemias, tumorigenesis, etc.
UGT1A3
There are 4 phenotypes of the UGT1A3 allele, UGT1A3-1, UGTIA3-2, UGT1A3-3, and UGT1A3-4. UGT1A3 is inactivated by forming glucuronide conjugates with many drugs and toxicants.
UGT1A8
UGT1A8 is part of the UGT1 locus, which is involved in the metabolism of dietary and environmental carcinogens. It is expressed in the gastrointestinal tract and extrahepatic tissues. The four alleles of UGT1A8 are UGT1A8α1, UGT1A8β1, UGT1A8β2 and UGT1A8β3.
Journal: Frontiers in Genetics
IF: 2.8
Published: 2020
Results: Through genome analysis, 10 AccUGT genes were identified, all of which showed upregulated expression under various pesticide treatments, indicating their involvement in pesticide detoxification. Functional experiments revealed that overexpression of AccUGT2B20-like in Escherichia coli enhanced resistance to oxidative stressors. Conversely, RNAi-mediated silencing of AccUGT2B20-like in honeybees reduced the expression of antioxidant-related genes, decreased activities of superoxide dismutase (SOD), catalase (CAT), and peroxidase (POD), and increased malondialdehyde (MDA) levels, exacerbating oxidative stress. These findings demonstrate that AccUGTs, particularly AccUGT2B20-like, contribute to pesticide resistance in Apis cerana cerana by mitigating oxidative stress, providing insights into the molecular basis of bee resilience to pesticides and supporting ecological balance preservation.
Fig.2 Phylogenetic analysis and tissue-specific expression patterns of Apis cerana cerana UGT genes. (Cui, et al., 2020)
CD BioGlyco applies proven technologies for gene editing to realize the construction of multi-domain in vitro models. Our experienced researchers provide customized Gene Editing services and advice upon request. In addition to UGT, we also offer GAG Polymerase Engineering Service and Sulfotransferase Engineering Service. For detailed UGT gene editing services, please feel free to contact us.
We synthesize custom glycan libraries for use in screening or as acceptor substrates for your engineered enzyme.
We offer full-service synthesis of complex glycoconjugates for drug discovery and vaccine development.
We provide comprehensive solutions for the synthesis, modification, and analysis of sialic acids.
Reference